PDUFA V: What you need to know about the upcoming Prescription Drug User Fee Act
Rho
21-Feb-2012 - Outsourcing Pharma presents its weekly round-up of the latest new faces and appointments in the pharmaceutical industry, including news from Patheon, CTI and PRECOS.
16-Feb-2012 - Quintiles has added to its commercial services capabilities in the Middle East and North Africa (MENA) region through an agreement with UAE-based Dayarn Pharma.
15-Feb-2012 - Almac says unexpectedly high demand for analytical services prompted it to double of capacity at the laboratory at its US headquarters.
14-Feb-2012 - Outsourcing-Pharma presents its weekly round-up of the latest chops and changes within the pharmaceutical jobs market, with news from Patheon, AmerisourceBergen and Premier Research.
13-Feb-2012 - US-based oncology services firm Biologics Inc will distribute a kidney cancer drugs being under a new contract with Pfizer.
09-Feb-2012 - Outsourcing-Pharma presents its latest round-up of the appointments within the pharmaceutical industry, including news from Icon, Merck and Clinipace.
07-Feb-2012 - Logistics contractor Marken plans to ramp up its activities in China with a new Beijing depot set to open later this year.
06-Feb-2012 - The desire to be an all-encompassing ‘one stop shop’ may be common to both contract research organisations (CRO) and contract manufacturing organisations (CMO), but that does not mean the terms CRO and CMO are synonymous say industry leaders.
02-Feb-2012 - Trial logistics firm Marken says new expert development team will create ‘industry changing,’ cold chain technologies.
02-Feb-2012 - Outsourcing-Pharma presents its weekly round-up of the latest career changes within the pharmaceutical industry, including news from Icon, AbelsonTaylor and Chiltern.
02-Feb-2012 - Almac says its first leap into Next Generation Sequencing (NGS) data analysis services is a much needed-change from the industry’s current “one-size-fits-all” offering.
31-Jan-2012 - TNT Express is now offering temperature-controlled logistics services to support global distribution of biologics.
30-Jan-2012 - HUYA Bioscience says it will strengthen bonds between Chinese drug innovators and worldwide developers and through its new partnership with the Tianjin Institute of Pharmaceutical Research (TIPR).
26-Jan-2012 - Outsourcing-Pharma presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Patheon, Wolfe Laboratories, and Premier Research.
25-Jan-2012 - Clinical Financial Services (CFS) has made its first foray into the global market after opening a new office in Edinburgh, Scotland.
24-Jan-2012 - Outsourcing is a gamble for the industry that needs a closer collaborative approach if pharma firms want a successful performance, according to new research.
23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.
23-Jan-2012 - Almac says its isotope chemistry facility and its lab division both passed UK regulators’ inspections.
19-Jan-2012 - SGS’ new analytical lab in Mumbai, India will open later this week just six months after the analytical services firm began its construction .
19-Jan-2012 - InVentiv will boost its market research and analytics offering with the acquisition of SDI’s medical audit activities.
19-Jan-2012 - Outsourcing-Pharma presents its weekly round-up of the latest career changes in the pharmaceutical industry, including news from Premier Research, Almac, and AAI Pharma.
18-Jan-2012 - Quintiles has invested £3m ($4.6m) in a new UK-based biomarker R&D company in a continuation of its efforts to build in the field of personalised medicines.
18-Jan-2012 - Training and consultancy firm NSF Health Sciences (NSF-DBA) has acquired Pink Associates in a bid to broaden its service offering.
17-Jan-2012 - inVentiv Health says it will now offer a one-stop-shop for pharma and biotech training services after merging its subsidiaries Pharmaceutical Institute and Preceptiv Learning Solutions.
16-Jan-2012 - Contract services firm Warnex will leave the Toronto Stock Exchange (TSX) after failing to meet the requirements for continued listing.